Growing evidence shows that the deregulation of the circadian clock plays an important role in the development of malignant tumors, including gliomas. However, the molecular mechanisms of genes controlling circadian rhythm in glioma cells have not been explored. Using reverse transcription polymerase chain reaction and immunohistochemistry techniques, we examined the expression of the most important clock genes, clock, in 67 gliomas.Our results revealed that asynchronized expression of the clock gene was found in cancerous tissues in comparison with paired non-cancerous tissues. The expression levels of clock mRNA in grade III or IV glioma was significantly different from the surrounding non-tumor tissues (P , 0.01). The difference in the expression of clock in low-grade (grades 1 and II) gliomas and the surrounding non-glioma tissues was insignificant (P . 0.05). The intensity of immunoactivity for Clock in highgrade gliomas was significantly higher than that of low-grade gliomas (r 5 20.403, P 5 0.012 , 0.05), non-tumor tissues around high-grade gliomas (r 5 20.376, P 5 0.027 , 0.05), while there was no difference in the intensity of immunoactivity for Clock between low-grade gliomas and the surrounding non-tumor tissues (P . 0.05). The expression of PCNA (Proliferating Cell Nuclear Antigen) protein in highgrade gliomas was significantly higher than that of low-grade gliomas (P , 0.05). In this study, we found that the expression of clock in glioma cells and in the surrounding non-tumor cells.
Introduction
Circadian rhythms, which are daily oscillations regulated by an endogenous clock (1-4), enable organisms to adapt to daily environmental changes such as light, temperature and social communication. They serve to synchronize multiple molecular, biochemical, physiological and behavioral processes (5-7). In mammals, the master circadian clock resides in the suprachiasmatic nucleus (SCN) of the anterior hypothalamus. In SCN, circadian rhythms are generated by a set of core clock genes including period (Per1-Per3), Clock, Bmal1, and cry (Cry1-2). Clock and baml1, two basic helix-loop-helix heterodimer transcriptional activators, are positive regulators that bind E-boxes in the promoter of various genes (8, 9) . Circadian rhythms influence many physiologic processes and pathologic conditions including cancer (10, 11) . Epidemiologic studies have shown that disruption of normal circadian rhythm may increase the risk of developing various cancer types such as breast, prostate, colorectal, and endometrial cancers (12) (13) (14) (15) (16) (17) . Additionally, clock has been reported to be deregulated in several human cancers (18) . Thus, we suggest that abnormal expression of clock genemay potentially develop certain types of cancer.
Gliomas are the most common form of primary brain tumorsand its morbidity is increasing year by year. However, the precise mechanism is not elucidated till now. Differential expression of circadian clock genes in glioma and non-tumor cells may provide a molecular basis for manifesting this mechanism (19) . In the present study, we used immunohistochemical staining; RT-PCR to explore the expression level changes in the most important circadian genes (clock) in glioma.
Materials and Methods

Samples
From July 2009 to December 2010, 67 patients with diffuse subcortical gliomas were operated on in the Affiliated Hospital of Ningxia Medical University, and the glioma tissue samples of these patients were used for this study. Sixty seven resected glioma tissue samples with the surrounding nontumorous tissues were collected. The paired non-tumorous tissue confirmed by histopathological analysis was collected from the normal part of glioma tissue without contamination from glioma cells. The age of the patient ranged from 23 to 68 with a mean of 40.6 years, with 42 men and 25 women. The tissues were frozen or formalin-fixed immediately after surgical resection and stored in liquid nitrogen as Hui et al. previously described (20) . The glioma tissue and tumor free specimens were surgically obtained between 11:00 and 15:00. The glioma tissues in our study include 32 astrocytomas, 24 oligodendrogliomas and 11 glioblastoma. According to WHO pathology grading, 15 cases were stage I, 20 were stage II, 23 were stage III, and 9 were stage IV.
RT-PCR
Let the tumor and non-tumor tissues steep in 0.4% DEPC after surgical resection. Total RNA was isolated with Trizol reagent (Invitrogen) and RT-PCR for human clock, GAPDH primers were used as an internal control. Details of the primer are given in Table I . After gel electrophoresis, we observed the results on a UV detector and scanned the gel using a Multi-Analyst (Bio-Rad) gel imaging analysis system. We then analyzed the determination of amplification products of gray value bands to hGAPDH as internal reference for the ratio, semi-quantitative analysis of clock mRNA expression level for statistical analysis.
Immunohistochemistry
Paraffin-embedded tissue sections (4 μm) on poly-1-lysine coated slides were deparaffinized. The sections were treated with EDTA in a pressure cooker, heated at boiling temperature for 2.5 minutes, cooled and incubated with 3% H 2 O 2 for ten minutes to block endogenous peroxidase, and then incubated with gradient alcohol and washed in phosphate buffered saline (PBS) three times for two minutes each time. After Table I Gene nomenclature, primer sequences and predicted size of the amplified products for the different genes studied.
Gene
Forward primer Reverse primer Size (bp) Clock AGTTAGGGCTGAAAGACGACG TTGCTTCTATCATGCGTGTCC 479 bp hGAPDH AGAAGGCTGGGGCTCATTTG AGGGGGCCATCCACAGTCTTC 266 bp being bathed in PBS, sections were incubated with antibodies for clock (1:400, Santa Cruz Biotechnology, CA) and PCNA (1:200, Abnova Co., Taiwan) for two hours at 378C.
The slides were washed three times with PBS and incubated with secondary anti-body, at 378C for 30 minutes, then thoroughly washed three times with PBS. Detection of immunostaining was performed using diaminobenzidine (DAB, Zhongshan Goldenbridge Biotechnology Co. China.) as chromogene, and then a counterstain was performed using haematoxylin. Staining was evaluated by a pathologist and an investigator blind to diagnosis and sections were classified as positive or negative. Cell nucleus can be observed through staining.
The numbers of positive and negative cells were determined in four random fields (3100 magnification), and the percentage of positive cells was then calculated. Positive cells had yellow staining in the cell nucleus. Cells were quantified by cell numbers per one high power field , with no positive cell graded as 0, 1-25% of the cells as 1, 26-50% as 2, 51-75% as 3, 75-100% as 4. The staining intensity was graded, with no coloration graded as 0, light yellow as 1, yellow as 2, and brown as 3. The two scales were multiplied, the cells with a value greater than or equal to 2.0 were counted as positive (21).
Statistical Analysis
The association between tumor grade (high-grade/low-grade gliomas) and expression of the investigated proteins (negative/ positive) was assessed using the Spearman, Chi-Square Test and Two-sample t-test, included in the Statistical Package for the Social Science, version 13.0. Using Spearman Correlation to analyse correlation between the expression of CLOCK and PCNA. 
Figure 2:
Immunohistochemical analysis of CLOCK for representative cases and positive staining in the nucleus are found (320). 1, 3 were the tissues of grade I or II glioma and the non-tumor brain tissues around grade I or II glioma tissue; 2, 4 were the tissues grade III or IV glioma and the non-tumor brain tissues around the grade of III or IV glioma. 
Results
The Express of Clock Gene in Glioma and Non-tumor Tissue
Lower levels of clock mRNA were identified in gliomas compared with non-tumor tissues around glioma (Figure 1) . The expression levels of clock mRNA in the glioma tissus were significantly different from those in normal brain tissue cells (P , 0.01, Two-sample t-test, Table II ). There was no significant difference in the intensity of RT-PCR for clock mRNA between non-tumor tissues around glioma and low-grade gliomas (r 5 20.109, P 5 0.527 . 0.05), whereas the expression of clock mRNA in high-grade is significantly higher than that of low grade (r 5 20.542, P 5 0.020 , 0.05) non-tumor tissues around glioma (r 5 20.801, P 5 0.039 , 0.05).
The Level of Clock and PCNA in Glioma and Non-tumor Tissue
The expression of clock can be observed in gliomas and normal tissues (non-tumor brain sample) at different levels, all the staining was in the cell nucleus ( Figure 2) . The expression of clock in glioma tissues is 70.20% (47/67), while out of 67 non-tumor brain tissues, 35 were clock-positive (52.23%).
The expression levels of clock in the glioma cells were significantly different from those in non-tumor brain tissue cells (P , 0.01, Two-sample t-test). There was no significant 
Figure 3:
Immunohistochemical stain for determining PCNA protein expression and positive staining in the nucleus and cytoplasm are found in glioma (320); 1, 2 were the tissue of grade I or II glioma and the tissue grade III or IV glioma; 3, 4 were the non-tumor tissues around grade I or II glioma tissue and the non-tumor tissues around the grade of III or IV glioma.
difference in the expression rates of CLCOK between lowgrade gliomas (I, II) and non-tumor tissues around gliomas (P . 0.05, Chi-Square test, Table III ), whereas the expression of CLOCK in high-grade gliomas (III, IV) is significantly high than that of low-grade gliomas (r 5 20.403, P 5 0.012 , 0.05), non-tumor tissues around high-grade gliomas (r 5 20.376, P 5 0.027 , 0.05).
Finally, the abilities of proliferation were measured by PCNA protein (Figure 3 ). The expression level of PCNA in grade I or II glioma tissue was obviously lower in grade III or IV glioma tissue (P , 0.05, Chi-Square test, Table IV) , there were no obvious differences on the expression of PCNA between non-tumor tissue around grade I or II glioma and non-tumor tissue around III or IV glioma (P . 0.05, Chi-Square test).
The Analyse Correlation between the Expression of CLOCK and PCNA in Glioma
The co expression of CLOCK and PCNA protein was higher in grade III and IV than in grade I and II in gliomas by using Spearman rank related coefficient rs (r 5 0.273, P , 0.05, Table V) .
Discussion
Generally speaking, the circadian clock and cell cycle are two global regulatory systems in most eukaryotic organisms (22) . Recently, research has shown that the circadian system is not only essential for proper growth control, but it also regulates cell proliferation and apoptosis (10, 11, 22, 23) . As a set of core circadian genes, Clock have a role in a wide variety of physiological processes, including the circadian rhythm of cells and sustaining the normal cell cycle. It has been reported that 2-10% of all mammalian genes are clockcontrolled (24) (25) (26) (27) , and recent studies reported that approximately 7% of all clock-controlled genes identified in rodents regulate either cell proliferation or apoptosis (26). Therefore, the development of glioma may be related to the disruption of clock.
In this study, we analyzed and compared the expression status of transcriptional activation of Clock and the CLOCK proteins in tumor and non-tumor tissues obtained at the same time in each case so that the tissue pairs were synchronized with respect to the same circadian clock. And and we find differential expression patterns in the clock genes in glioma cells in most of the glioma cases (47/67) when analyzed in comparison with their paired nearby non-cancer brain tissues. The deregulation of the circadian clock may be one of the most important factors in the proliferation of glioma. Since expression of clock play a central role in circadian rhythm, our results suggest that the circadian clock in the tumor cells of most glioma cases behaves differently than in nearby non-cancer brain tissues.
Furthermore, we also observed clock expression patterns in different cell populations of the different grade glioma tissue to be 87.5% for high-grade and 54.29% for low-grade. In nearby non-tumor brain tissue around high-grade and low-grade, the expression of clock are 51.43% and 53.13, suggesting that several asynchronized circadian clocks may be in operation in the same glioma tissue. This can show that the heterogeneity has been in glioma cell population in glioma tissue. Our results that supported the hypothesis that the heterogeneity has been in glioma cell population in glioma tissue.
We observed a statistically significant difference of expression of clock between low-grade of gliomas tissues and nontumor brain tissues (the results of immunohistochemistry and RT-PCR is individually P , 0.01). The co expression of CLOCK and PCNA protein was higher in grade III and IV than in grade I and II in gliomas (the results of immunohistochemistry is P , 0.05). The PCNA is Proliferating Cell Nuclear Antigen, it can be the index of cell functional status, especially tumor cell proliferation and differentiation. Our results may show that clock proteins probably related with the development and progression stage of gliomas. Aaron et al. (18) report that breast tissue samples taken from healthy controls had significantly lower CLOCK expression than tissue from patients with breast cancer, and that tumor tissue had higher CLOCK levels than adjacent normal tissue, and the expression of several cancer-related transcripts is significantly altered following CLOCK gene knockdown. We found a association of expression of CLOCK among tumor grades (r 5 20.403, P 5 0.012 , 0.05) and the expression of clock mRNA among tumor grade (r 5 20.542, P 5 0.020 , 0.05). Taken together, we suggest the high expression of clock may play a more important role in the development of glioma.
Recently, studies have shown that fibroblasts derived from CLOCK-deficient mice had significantly inhibited cell growth and proliferation relative to fibroblasts from wildtype mice (10). Miller et al. (28) found that lymphoid tissues from mice with a functional deficiency in CLOCK had diminished proliferation and increased apoptotic activity and suggested that Clock mutation cells fail to respond to mitogenic signals and/or experience a block at the G 1 /S transition. It was also noted that the intracellular circadian clockwork is able to control the cell division cycle directly.
In another separate study, it was observed that the loss of Per1 protein was commonly observed in human endometrial carcinoma but not in the adjacent normal cells (29). Xia et al. (19) propose that inactivation of the Per1 and Per2 in glioma cells may result in deregulation of the cell cycles thus favoring the proliferation of glioma cells, as deregulated expression of the Per1 genes is common in gliomas. A recent study also shows that CLOCK is a histone acetyltransferase, adding another potential avenue by which CLOCK may regulate transcriptional activation (30). And the Model of circadian clock in mammals is that Clock and Bmal1 are transcriptional activators that make up the Clock-Bmal1 complex, which activates the transcription of Per genes; the Per proteins is one of transcriptional repressors that interfere with the activity of Clock-Bmal1 and down-regulate transcription of genes controlled by these factors. Based on these results, we propose that low expression of the Per1 genes in glioma may result in deregulated expression of clock and the disruption of the control of normal cell growth and proliferation, thus benefiting the survival of glioma cells.
In conclusion, we found that deregulated expression of the Clock genes is common in glioma; and these findings provide further evidence in support of a role for circadian genes in glioma development by benefiting the gowth and proliferation of cancer cells, and suggest that CLOCK may have oncogenic property.
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